Category: Medicare
-
Medicare Mess Sends Humana Shares on Worst Fall Since Financial Crisis
•
(Bloomberg) — Humana Inc. investors haven’t had a hard time. Nothing this bad since the global financial crisis 15 years ago. Most read from Bloomberg The health insurer’s stock price fell 22% on Tuesday and Wednesday alone, which last happened in February 2009. It continued to decline, with shares suffering…
-
CVS Health upgraded at TD Cowen after insurer unveils 2025 Medicare Advantage plan By Investing.com
•
Investing.com – Analysts at TD Cowen raised their rating on CVS Health (NYSE:) to “buy” from “hold,” citing changes to Medicare Advantage plan benefits for 2025 announced earlier this week. Along with peers like Humana (NYSE:) and Cigna (NYSE:), CVS unveiled details of next year’s government-backed health insurance plans for…
-
CVS Health upgraded at TD Cowen after insurer unveils 2025 Medicare Advantage plan By Investing.com
•
Investing.com – Analysts at TD Cowen raised their rating on CVS Health (NYSE:) to “buy” from “hold,” citing changes to Medicare Advantage plan benefits for 2025 announced earlier this week. Along with peers like Humana (NYSE:) and Cigna (NYSE:), CVS unveiled details of next year’s government-backed health insurance plans for…
-
Health insurers unveil Medicare Advantage plans for 2025 By Reuters
•
(Reuters) – CVS Health (NYSE:) and Cigna (NYSE:) on Tuesday released details on next year’s government-backed health insurance plans for people 65 and older, saying some members will pay a $0 monthly premium for drugs. described. These announcements come ahead of the start of enrollment in Medicare Advantage plans on…
-
Medicare Advantage shopping tips: Avoid this enrollment mistake
•
The shopping season for Medicare coverage is about to begin. With that comes the annual onslaught of TV ads and choices to consider. People who qualify for the federal government Medicare program From October 15 to December 7, you’ll have access to Medicare Advantage plans for 2025, which are privately…
-
Medicare coverage of Novo Nordisk’s Wegovy could cost up to $145B annually
•
aprott/iStock via Getty Images Novo Nordisk’s (NVO) weight-loss drug Wegovy (semaglutide), which can be prescribed to Medicare beneficiaries with obesity and cardiovascular disease, could cost the system up to $145 billion a year. If all eligible beneficiaries receive Wegovy If achieved, it would cost Medicare between $34 billion and $145…
-
Does Medicare cover concierge medicine?
•
Many of us have experienced the frustration of trying to find a doctor who is accepting new patients, long waits to see the doctor, and rushing appointments. Enter concierge medicine. “Concierge medicine is when people pay an annual membership fee to get a more personalized approach to their health care,”…
-
What Medicare beneficiaries need to know about generic medications
•
Generic drugs save Medicare’s 43 million beneficiaries billions of dollars annually compared to the cost of their brand-name counterparts, and are typically sold for about 80% less. But if you think that all generic drugs are the same regarding side effects, manufacturing quality, price, and Part D prescription drug coverage,…